Eli Lilly’s New Oral Weight-Loss Drug Receives Swift FDA Approval
William Strasmore
April 1, 2026
Federal regulators have granted expedited approval to Eli Lilly’s latest pharmaceutical breakthrough, Foundayo (orforglipron). This daily oral medication is designed to treat obesity and weight-related